Carregant...
Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib
Marginal zone lymphomas (MZLs) consist of a diverse family of malignancies, which are derived from B-cells. The disease subtypes are recognized extranodal, nodal, and splenic MZLs. The disease characteristics, clinical course, and treatment vary considerably based on the site of involvement. In 2017...
Guardat en:
| Publicat a: | Cancer Manag Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5877869/ https://ncbi.nlm.nih.gov/pubmed/29628774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S133291 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|